Cargando…

Thiamine diphosphate reduction strongly correlates with brain glucose hypometabolism in Alzheimer’s disease, whereas amyloid deposition does not

BACKGROUND: The underlying mechanism of brain glucose hypometabolism, an invariant neurodegenerative feature that tightly correlates with cognitive impairment and disease progression of Alzheimer’s disease (AD), remains elusive. METHODS: Positron emission tomography with 2-[(18)F]fluoro-2-deoxy-d-gl...

Descripción completa

Detalles Bibliográficos
Autores principales: Sang, Shaoming, Pan, Xiaoli, Chen, Zhichun, Zeng, Fan, Pan, Shumei, Liu, Huimin, Jin, Lirong, Fei, Guoqiang, Wang, Changpeng, Ren, Shuhua, Jiao, Fangyang, Bao, Weiqi, Zhou, Weiyan, Guan, Yihui, Zhang, Yiqiu, Shi, Hongcheng, Wang, Yanjiang, Yu, Xiang, Wang, Yun, Zhong, Chunjiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831864/
https://www.ncbi.nlm.nih.gov/pubmed/29490669
http://dx.doi.org/10.1186/s13195-018-0354-2
_version_ 1783303215869067264
author Sang, Shaoming
Pan, Xiaoli
Chen, Zhichun
Zeng, Fan
Pan, Shumei
Liu, Huimin
Jin, Lirong
Fei, Guoqiang
Wang, Changpeng
Ren, Shuhua
Jiao, Fangyang
Bao, Weiqi
Zhou, Weiyan
Guan, Yihui
Zhang, Yiqiu
Shi, Hongcheng
Wang, Yanjiang
Yu, Xiang
Wang, Yun
Zhong, Chunjiu
author_facet Sang, Shaoming
Pan, Xiaoli
Chen, Zhichun
Zeng, Fan
Pan, Shumei
Liu, Huimin
Jin, Lirong
Fei, Guoqiang
Wang, Changpeng
Ren, Shuhua
Jiao, Fangyang
Bao, Weiqi
Zhou, Weiyan
Guan, Yihui
Zhang, Yiqiu
Shi, Hongcheng
Wang, Yanjiang
Yu, Xiang
Wang, Yun
Zhong, Chunjiu
author_sort Sang, Shaoming
collection PubMed
description BACKGROUND: The underlying mechanism of brain glucose hypometabolism, an invariant neurodegenerative feature that tightly correlates with cognitive impairment and disease progression of Alzheimer’s disease (AD), remains elusive. METHODS: Positron emission tomography with 2-[(18)F]fluoro-2-deoxy-d-glucose (FDG-PET) was used to evaluate brain glucose metabolism, presented as the rate of 2-[(18)F]fluoro-2-deoxy-d-glucose standardized uptake value ratio (FDG SUVR) in patients with AD or control subjects and in mice with or without thiamine deficiency induced by a thiamine-deprived diet. Brain amyloid-β (Aβ) deposition in patients with clinically diagnosed AD was quantified by performing assays using (11)C-Pittsburgh compound B PET. The levels of thiamine metabolites in blood samples of patients with AD and control subjects, as well as in blood and brain samples of mice, were detected by high-performance liquid chromatography with fluorescence detection. RESULTS: FDG SUVRs in frontal, temporal, and parietal cortices of patients with AD were closely correlated with the levels of blood thiamine diphosphate (TDP) and cognitive abilities, but not with brain Aβ deposition. Mice on a thiamine-deprived diet manifested a significant decline of FDG SUVRs in multiple brain regions as compared with those in control mice, with magnitudes highly correlating with both brain and blood TDP levels. There were no significant differences in the changes of FDG SUVRs in observed brain regions between amyloid precursor protein/presenilin-1 and wild-type mice following thiamine deficiency. CONCLUSIONS: We demonstrate, for the first time to our knowledge, in vivo that TDP reduction strongly correlates with brain glucose hypometabolism, whereas amyloid deposition does not. Our study provides new insight into the pathogenesis and therapeutic strategy for AD. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13195-018-0354-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5831864
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58318642018-03-05 Thiamine diphosphate reduction strongly correlates with brain glucose hypometabolism in Alzheimer’s disease, whereas amyloid deposition does not Sang, Shaoming Pan, Xiaoli Chen, Zhichun Zeng, Fan Pan, Shumei Liu, Huimin Jin, Lirong Fei, Guoqiang Wang, Changpeng Ren, Shuhua Jiao, Fangyang Bao, Weiqi Zhou, Weiyan Guan, Yihui Zhang, Yiqiu Shi, Hongcheng Wang, Yanjiang Yu, Xiang Wang, Yun Zhong, Chunjiu Alzheimers Res Ther Research BACKGROUND: The underlying mechanism of brain glucose hypometabolism, an invariant neurodegenerative feature that tightly correlates with cognitive impairment and disease progression of Alzheimer’s disease (AD), remains elusive. METHODS: Positron emission tomography with 2-[(18)F]fluoro-2-deoxy-d-glucose (FDG-PET) was used to evaluate brain glucose metabolism, presented as the rate of 2-[(18)F]fluoro-2-deoxy-d-glucose standardized uptake value ratio (FDG SUVR) in patients with AD or control subjects and in mice with or without thiamine deficiency induced by a thiamine-deprived diet. Brain amyloid-β (Aβ) deposition in patients with clinically diagnosed AD was quantified by performing assays using (11)C-Pittsburgh compound B PET. The levels of thiamine metabolites in blood samples of patients with AD and control subjects, as well as in blood and brain samples of mice, were detected by high-performance liquid chromatography with fluorescence detection. RESULTS: FDG SUVRs in frontal, temporal, and parietal cortices of patients with AD were closely correlated with the levels of blood thiamine diphosphate (TDP) and cognitive abilities, but not with brain Aβ deposition. Mice on a thiamine-deprived diet manifested a significant decline of FDG SUVRs in multiple brain regions as compared with those in control mice, with magnitudes highly correlating with both brain and blood TDP levels. There were no significant differences in the changes of FDG SUVRs in observed brain regions between amyloid precursor protein/presenilin-1 and wild-type mice following thiamine deficiency. CONCLUSIONS: We demonstrate, for the first time to our knowledge, in vivo that TDP reduction strongly correlates with brain glucose hypometabolism, whereas amyloid deposition does not. Our study provides new insight into the pathogenesis and therapeutic strategy for AD. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13195-018-0354-2) contains supplementary material, which is available to authorized users. BioMed Central 2018-03-01 /pmc/articles/PMC5831864/ /pubmed/29490669 http://dx.doi.org/10.1186/s13195-018-0354-2 Text en © The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Sang, Shaoming
Pan, Xiaoli
Chen, Zhichun
Zeng, Fan
Pan, Shumei
Liu, Huimin
Jin, Lirong
Fei, Guoqiang
Wang, Changpeng
Ren, Shuhua
Jiao, Fangyang
Bao, Weiqi
Zhou, Weiyan
Guan, Yihui
Zhang, Yiqiu
Shi, Hongcheng
Wang, Yanjiang
Yu, Xiang
Wang, Yun
Zhong, Chunjiu
Thiamine diphosphate reduction strongly correlates with brain glucose hypometabolism in Alzheimer’s disease, whereas amyloid deposition does not
title Thiamine diphosphate reduction strongly correlates with brain glucose hypometabolism in Alzheimer’s disease, whereas amyloid deposition does not
title_full Thiamine diphosphate reduction strongly correlates with brain glucose hypometabolism in Alzheimer’s disease, whereas amyloid deposition does not
title_fullStr Thiamine diphosphate reduction strongly correlates with brain glucose hypometabolism in Alzheimer’s disease, whereas amyloid deposition does not
title_full_unstemmed Thiamine diphosphate reduction strongly correlates with brain glucose hypometabolism in Alzheimer’s disease, whereas amyloid deposition does not
title_short Thiamine diphosphate reduction strongly correlates with brain glucose hypometabolism in Alzheimer’s disease, whereas amyloid deposition does not
title_sort thiamine diphosphate reduction strongly correlates with brain glucose hypometabolism in alzheimer’s disease, whereas amyloid deposition does not
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831864/
https://www.ncbi.nlm.nih.gov/pubmed/29490669
http://dx.doi.org/10.1186/s13195-018-0354-2
work_keys_str_mv AT sangshaoming thiaminediphosphatereductionstronglycorrelateswithbrainglucosehypometabolisminalzheimersdiseasewhereasamyloiddepositiondoesnot
AT panxiaoli thiaminediphosphatereductionstronglycorrelateswithbrainglucosehypometabolisminalzheimersdiseasewhereasamyloiddepositiondoesnot
AT chenzhichun thiaminediphosphatereductionstronglycorrelateswithbrainglucosehypometabolisminalzheimersdiseasewhereasamyloiddepositiondoesnot
AT zengfan thiaminediphosphatereductionstronglycorrelateswithbrainglucosehypometabolisminalzheimersdiseasewhereasamyloiddepositiondoesnot
AT panshumei thiaminediphosphatereductionstronglycorrelateswithbrainglucosehypometabolisminalzheimersdiseasewhereasamyloiddepositiondoesnot
AT liuhuimin thiaminediphosphatereductionstronglycorrelateswithbrainglucosehypometabolisminalzheimersdiseasewhereasamyloiddepositiondoesnot
AT jinlirong thiaminediphosphatereductionstronglycorrelateswithbrainglucosehypometabolisminalzheimersdiseasewhereasamyloiddepositiondoesnot
AT feiguoqiang thiaminediphosphatereductionstronglycorrelateswithbrainglucosehypometabolisminalzheimersdiseasewhereasamyloiddepositiondoesnot
AT wangchangpeng thiaminediphosphatereductionstronglycorrelateswithbrainglucosehypometabolisminalzheimersdiseasewhereasamyloiddepositiondoesnot
AT renshuhua thiaminediphosphatereductionstronglycorrelateswithbrainglucosehypometabolisminalzheimersdiseasewhereasamyloiddepositiondoesnot
AT jiaofangyang thiaminediphosphatereductionstronglycorrelateswithbrainglucosehypometabolisminalzheimersdiseasewhereasamyloiddepositiondoesnot
AT baoweiqi thiaminediphosphatereductionstronglycorrelateswithbrainglucosehypometabolisminalzheimersdiseasewhereasamyloiddepositiondoesnot
AT zhouweiyan thiaminediphosphatereductionstronglycorrelateswithbrainglucosehypometabolisminalzheimersdiseasewhereasamyloiddepositiondoesnot
AT guanyihui thiaminediphosphatereductionstronglycorrelateswithbrainglucosehypometabolisminalzheimersdiseasewhereasamyloiddepositiondoesnot
AT zhangyiqiu thiaminediphosphatereductionstronglycorrelateswithbrainglucosehypometabolisminalzheimersdiseasewhereasamyloiddepositiondoesnot
AT shihongcheng thiaminediphosphatereductionstronglycorrelateswithbrainglucosehypometabolisminalzheimersdiseasewhereasamyloiddepositiondoesnot
AT wangyanjiang thiaminediphosphatereductionstronglycorrelateswithbrainglucosehypometabolisminalzheimersdiseasewhereasamyloiddepositiondoesnot
AT yuxiang thiaminediphosphatereductionstronglycorrelateswithbrainglucosehypometabolisminalzheimersdiseasewhereasamyloiddepositiondoesnot
AT wangyun thiaminediphosphatereductionstronglycorrelateswithbrainglucosehypometabolisminalzheimersdiseasewhereasamyloiddepositiondoesnot
AT zhongchunjiu thiaminediphosphatereductionstronglycorrelateswithbrainglucosehypometabolisminalzheimersdiseasewhereasamyloiddepositiondoesnot